×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
9688 views

Modérateur : Pr Jean-Marc Classe

 

18:00
Qu’est-ce que la réponse pathologique complète et quels sous types sont concernés ?
Dr Anne Vincent-Salomon
 
18:15
A qui proposer de la CNA alors que la chirurgie première est faisable et quelles sont les perspectives ?
Dr Mahasti Saghatchian
 
18:30
A qui proposer une chimiothérapie néoadjuvante alors que l’intervention première est faisable et existe-t-il des perspectives de désescalade chirurgicale ?
Dr Marie Bannier
 
18:45
Quel impact sur la chirurgie axillaire ?
Pr Jean-Marc Classe
 
19:00 Débat/discussion - Réponses aux questions

 

Shooting date : 2021-12-21
Last update : 2022-03-09
1 comment
Join the Discussion
  • Bradley Sarnick Farel M. Merci

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Tuesday, March 25th 2025 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, March 25th 2025 from 06am to 07:30am (GMT+1)
    San Francisco : Tuesday, March 25th 2025 from 08am to 09:30am (GMT+1)
    New York : Tuesday, March 25th 2025 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Tuesday, March 25th 2025 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Tuesday, March 25th 2025 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Tuesday, March 25th 2025 from 05pm to 06:30pm (GMT+1)
    Istanbul : Tuesday, March 25th 2025 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, March 25th 2025 from 08pm to 09:30pm (GMT+1)
    Bangkok : Tuesday, March 25th 2025 from 11pm to 12:30am (GMT+1)
    Shanghai : Wednesday, March 26th 2025 from 12am to 01:30am (GMT+1)
    Tokyo : Wednesday, March 26th 2025 from 01am to 02:30am (GMT+1)
    Sydney : Wednesday, March 26th 2025 from 02am to 03:30am (GMT+1)
    Wellington : Wednesday, March 26th 2025 from 04am to 05:30am (GMT+1)

    Où en sommes-nous dans la prise en charge du cancer du sein ?

    au stade métastatique RH+/HER2- ou HER2+

    Share
    Wednesday, April 20th 2022 from 06pm to 07:30pm (GMT+2)
    Honolulu : Wednesday, April 20th 2022 from 06am to 07:30am (GMT+2)
    San Francisco : Wednesday, April 20th 2022 from 09am to 10:30am (GMT+2)
    New York : Wednesday, April 20th 2022 from 12pm to 01:30pm (GMT+2)
    Buenos Aires : Wednesday, April 20th 2022 from 01pm to 02:30pm (GMT+2)
    Reykjavik : Wednesday, April 20th 2022 from 04pm to 05:30pm (GMT+2)
    London / Dublin : Wednesday, April 20th 2022 from 05pm to 06:30pm (GMT+2)
    Paris / Berlin : Wednesday, April 20th 2022 from 06pm to 07:30pm (GMT+2)
    Istanbul : Wednesday, April 20th 2022 from 07pm to 08:30pm (GMT+2)
    Moscou / Dubaï : Wednesday, April 20th 2022 from 08pm to 09:30pm (GMT+2)
    Bangkok : Wednesday, April 20th 2022 from 11pm to 12:30am (GMT+2)
    Shanghai : Thursday, April 21st 2022 from 12am to 01:30am (GMT+2)
    Tokyo : Thursday, April 21st 2022 from 01am to 02:30am (GMT+2)
    Sydney : Thursday, April 21st 2022 from 03am to 04:30am (GMT+2)
    Wellington : Thursday, April 21st 2022 from 05am to 06:30am (GMT+2)

    Cancer du sein

    Cycle de formation en oncologie gynécologique et sénologique de l’Institut Curie

    Share
    Thursday, May 25th 2023 from 06:30pm to 08pm (GMT+2)
    Honolulu : Thursday, May 25th 2023 from 06:30am to 08am (GMT+2)
    San Francisco : Thursday, May 25th 2023 from 09:30am to 11am (GMT+2)
    New York : Thursday, May 25th 2023 from 12:30pm to 02pm (GMT+2)
    Buenos Aires : Thursday, May 25th 2023 from 01:30pm to 03pm (GMT+2)
    Reykjavik : Thursday, May 25th 2023 from 04:30pm to 06pm (GMT+2)
    London / Dublin : Thursday, May 25th 2023 from 05:30pm to 07pm (GMT+2)
    Paris / Berlin : Thursday, May 25th 2023 from 06:30pm to 08pm (GMT+2)
    Istanbul : Thursday, May 25th 2023 from 07:30pm to 09pm (GMT+2)
    Moscou / Dubaï : Thursday, May 25th 2023 from 08:30pm to 10pm (GMT+2)
    Bangkok : Thursday, May 25th 2023 from 11:30pm to 01am (GMT+2)
    Shanghai : Friday, May 26th 2023 from 12:30am to 02am (GMT+2)
    Tokyo : Friday, May 26th 2023 from 01:30am to 03am (GMT+2)
    Sydney : Friday, May 26th 2023 from 03:30am to 05am (GMT+2)
    Wellington : Friday, May 26th 2023 from 05:30am to 07am (GMT+2)

    Cancer du sein RH+ : Quelles optimisations thérapeutiques en 2L métastatique ?

    Share
    Tuesday, March 19th 2024 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, March 19th 2024 from 06am to 07:30am (GMT+1)
    San Francisco : Tuesday, March 19th 2024 from 08am to 09:30am (GMT+1)
    New York : Tuesday, March 19th 2024 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Tuesday, March 19th 2024 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Tuesday, March 19th 2024 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Tuesday, March 19th 2024 from 05pm to 06:30pm (GMT+1)
    Istanbul : Tuesday, March 19th 2024 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, March 19th 2024 from 08pm to 09:30pm (GMT+1)
    Bangkok : Tuesday, March 19th 2024 from 11pm to 12:30am (GMT+1)
    Shanghai : Wednesday, March 20th 2024 from 12am to 01:30am (GMT+1)
    Tokyo : Wednesday, March 20th 2024 from 01am to 02:30am (GMT+1)
    Sydney : Wednesday, March 20th 2024 from 02am to 03:30am (GMT+1)
    Wellington : Wednesday, March 20th 2024 from 04am to 05:30am (GMT+1)

    Prise en charge actuelle pour les cancers du sein triples négatifs métastatiques

    Les webinars du réseau FEM-NET

    Share
    Scroll Up